The Zio ECG Utilization Software, or Zeus, system is an artificial intelligence algorithm that detects Afib and calculates an Afib burden estimate. The Zeus system can then send a report to a clinician, according to a July 22 press release.
The Zeus system algorithm will be paired with the Zio watch, the wearable component of the system, which was created through a partnership between iRhythm and Verily, an Alphabet company. The Zio watch also received FDA 510(k) clearance, according to the press release.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.